<?xml version="1.0" encoding="UTF-8"?>
<p id="Par103">NOX2 seems to be involved in the production of ROS during IV infection [
 <xref ref-type="bibr" rid="CR13">13</xref>, 
 <xref ref-type="bibr" rid="CR75">75</xref>]. In a mouse model, Nox2-derived superoxide is critical for IV-induced pulmonary damage. 
 <italic>Nox2</italic>
 <sup>
  <italic>–/–</italic>
 </sup> knockout (KO) mice exhibited a milder airway inflammation and less apoptosis in the alveolar epithelium after IV infection than did wild-type mice [
 <xref ref-type="bibr" rid="CR75">75</xref>]. The IV-mediated production of ROS and RNS was also decreased in 
 <italic>Nox2</italic>
 <sup>
  <italic>–/–</italic>
 </sup> KO mice [
 <xref ref-type="bibr" rid="CR75">75</xref>]. In another study, the titer of active competent viruses and their associated inflammatory activities were decreased in these KO mice [
 <xref ref-type="bibr" rid="CR72">72</xref>]. These findings suggest that NOX2 is a candidate for anti-ROS treatment to manage IV infection [
 <xref ref-type="bibr" rid="CR75">75</xref>].
</p>
